The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immune-related toxicities in non-small cell lung cancer: Real-life predictors of outcome to checkpoint inhibitors?
 
Emanuela Romano
Consulting or Advisory Role - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Roche/Genentech (Inst)
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb; Roche
 
Roberta Poli
No Relationships to Disclose
 
Clement Dumont
Travel, Accommodations, Expenses - Ipsen
 
Lisa Pietrogiovanna
No Relationships to Disclose
 
Marie Vigan
No Relationships to Disclose
 
Vincent Servois
No Relationships to Disclose
 
Francois-Clement Bidard
No Relationships to Disclose
 
Sophie Beaucaire-Danel
No Relationships to Disclose
 
Catherine Daniel
No Relationships to Disclose
 
Nicolas Girard
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; MSD; Novartis; Pfizer; Roche; Takeda
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; MSD Oncology; Roche
 
Segolene Hescot
No Relationships to Disclose
 
Alexia Savignoni
No Relationships to Disclose